Based on the aggregated intelligence of 160,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, phosphate producer Innophos Holdings (Nasdaq: IPHS) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Innophos' business and see what CAPS investors are saying about the stock right now.

Innophos facts

Headquarters

Cranbury, N.J.

Market Cap

$570 million

Industry

Specialty chemicals

Trailing-12-Month Revenue

$667 million

Management

CEO Randy Gress (since 2004)
CFO Neil Salmon (since 2009)

Return on Capital (Average, Past 3 Years)

18.9%

Cash/Debt

$132 million / $246 million

Dividend Yield

2.5%

Competitors

PotashCorp (NYSE: POT)
Mosaic (NYSE: MOS)
Agrium (NYSE: AGU)

Other Highly Rated Chemical Stocks

Dow Chemical (NYSE: DOW)
Monsanto (NYSE: MON)
Syngenta (NYSE: SYT)

Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.

On CAPS, 97.5% of the 910 members who have rated Innophos believe the stock will outperform the S&P 500 going forward. These bulls include Clint35 and All-Star johngg123, who is ranked in the top 10% of our community.

Late last year, Clint35 tapped the stock as a refreshingly small way to earn some income: "They're a small growing company. Their products are used in all kinds of other products. They already pay a dividend. ... Sounds like a winning combination."

In a pitch from last month, johngg123 helped Fools get up to speed on the Innophos story:

Going to a more food grade product mix (higher margins.) Volumes and utilization rate in mexico operations is increasing. As reported in the year-end conference call, 2010Q1 will be bad, but that will be the bottom. Price increases will follow. Earnings temporarily depressed by temporary legal issues. 2011 could be very nice. It is very important to remember that 2008 was a "perfect storm" year which resulted in unusually huge profits. That year should not be factored into the P/E too much. ... Good outlook on 2010, 2011.

What do you think about Innophos, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Monsanto is a Motley Fool Inside Value pick, and Syngenta is a Global Gains choice. The Fool owns shares of Innophos. The Fool's disclosure policy always gets a perfect score.